Newsfile Corp
24 Sept 2026, 23:35 UTC · 1h ago
Verdict
Headline leans bearish. We score HIMS −1.00 across two claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
2 claims · scored −1 bearish … +1 bullish · 1 new · 1 priced in
The Federal Trade Commission filed a lawsuit against Hims & Hers on July 29, 2026, alleging the company shared sensitive health data with platforms like Meta and Snap and deceived users regarding billing.
Priced inFTC action occurred July 29, 2026
So whatThe stock already dropped nearly 15% on this news, but subsequent regulatory fines could hit quarterly EPS.
More negative than 95% of claims this week
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
A class action lawsuit (Velanki v. Hims & Hers Health, Inc.) has been filed alleging violations of the Securities Exchange Act of 1934 for misleading statements regarding privacy and billing.
Newpress release dated September 24, 2026
So whatLead plaintiff appointment deadline is November 2, 2026, creating a legal overhang through Q4.
More negative than 78% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit and an FTC lawsuit alleging deceptive billing and privacy violations, resulting in a 15% share price drop.
Near neutral — 92% of ticker scores this week are stronger
Mentioned only as a third-party platform that received shared data from Hims & Hers; no direct impact on Meta's business indicated.
Near neutral — 92% of ticker scores this week are stronger
Mentioned only as a third-party platform that received shared data from Hims & Hers; no direct impact on Snap's business indicated.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1h ago
More positive than 13% of relationship scores this week
[a_to_b] Hims & Hers shared consumer health information with Snap's advertising platform.
—
HIMS hasn't traded since this ran. Last close $29.28 (Sep 24); the reaction starts at the next open.
HIMS chart →
